“Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s95, https://doi.org/10.25251/skin.4.supp.95.